Becker's naevus

Meet the patient

A 16-year-old boy lands in the skin clinic because his mother is convinced the "large dirty bruise" on his left shoulder is a mole turning nasty. It is a palm-sized, sharply demarcated brown patch studded with coarse dark hairs, first noticed at 13 and steadily growing hair ever since. It does not itch, does not hurt, and has never changed colour fast.[1]

The viva question this vignette always asks comes in three beats: what is it, is it dangerous, and what do you do? The answers — Becker's naevus, no, and reassure while you look past the skin for the syndrome — are the whole topic. Hold those three beats and everything below slots into place.[1]

The naming trap — a "naevus" with no naevus cells

Becker's naevus is not a melanocytic naevus, and the name is the first thing examiners use to trip you. There are no naevus cells in it; the brown comes from extra melanin parked in the basal keratinocytes, not from a proliferated naevus-cell clone. That is why the purer name — Becker melanosis — is the one to reach for at the viva table when the examiner asks "what is it really?"[1]

Properly, it is a cutaneous hamartoma: a disorganised but mature overgrowth of the structures that already live in that skin — epidermis, hair follicle and arrector pili smooth muscle. Not a tumour, not a naevus in the cellular sense, and certainly not a mole. Samuel William Becker, an American dermatologist, put two such hairy pigmented young men into the literature in 1949, and the lesion has held its place ever since as one of the canonical mosaic lesions of skin, alongside naevus sebaceous and the linear epidermal naevus.[1][2]

The hamartoma triad — three tissues, one clone, zero naevus cells

Histology is where Becker's naevus earns its "hamartoma" label, and it is one of the cleanest triads in dermatopathology. Three native structures overgrow together inside the patch:[1]

• Epidermis — acanthosis, papillomatosis and elongated rete ridges, with more melanin in the basal layer but no extra melanocytes. That basal pigment is the brown.
• Hair follicles — enlarged but otherwise normal follicles pushing out coarse terminal hair. That is the hypertrichosis.
• Arrector pili smooth muscle — hypertrophied dermal smooth-muscle bundles, sometimes palpable as a faint rubbery induration and stainable with smooth-muscle actin (SMA).[1]

The negative finding is the one that matters most: no naevus cells. That single absence is what separates Becker's naevus from a congenital melanocytic naevus and from melanoma, and it is the line to quote when the examiner hands you the slide.[1]

Why it wakes up at puberty — the androgen switch

The defining biological clue is pubertal onset, and the mechanism is androgen dependence. The hamartomatous clone is sitting in the skin from early life — a faint patch is sometimes recalled in retrospect from childhood — but it stays quiet until the androgen surge of puberty flips it on.[1]

Grande Sarpa and colleagues showed why: androgen receptor expression is up-regulated in the basal keratinocytes and the follicular outer-root-sheath cells inside a Becker's naevus compared with the surrounding normal skin. The lesion is, in effect, wired to over-respond to the very hormones that arrive at puberty.[3]

That single mechanism hands you the four androgen signatures to reel off at the viva — pubertal onset, male predominance, hypertrichosis, and intralesional acne — because all four are the same androgen switch read in different directions:[1]

1. Pubertal onset — the clone declares between 10 and 15 years as androgens rise.
2. Male predominance — a higher androgen milieu drives a louder phenotype.
3. Hypertrichosis — androgens flip the vellus follicles in the patch to coarse terminal ones.
4. Intralesional acne — androgen-sensitive pilosebaceous units inside the patch throw comedones and pustules, sometimes before anyone notices the pigmentation.[9]

The unilateral map — mosaicism and the lines of Blaschko

The sharp, geometric, one-sided shape is the signature of cutaneous mosaicism. Becker's naevus follows the lines of Blaschko — the S-shaped, wave-like paths along which embryonic epidermal clones migrate — not dermatomes and not Langer's lines. That is why a single lesion traces one Blaschko field: unilateral, sharply bounded, often geographic rather than patchy along a nerve.[1]

Happle's model is the one to carry: a postzygotic somatic mutation in a skin progenitor, whose daughter clone expands along a developmental field to become the lesion. Most cases are sporadic, but in the rare familial kindreds the pattern is paradominant — a heterozygous germline allele rides along silently because carriers look normal, and the lesion only emerges in a descendant when a second, somatic "loss of heterozygosity" event deletes the wild-type allele in a regional skin progenitor. One silent germline allele plus one somatic second hit equals one localised mosaic hamartoma.[2][4]

This is the framework that explains three otherwise puzzling things at once: why the lesion is unilateral and sharply bounded (one clonal field), why familial cases are rare but vertically transmitted (the silent germline allele), and why Becker's naevus syndrome strings together a spectrum of ipsilateral anomalies (the same clone spilling into the breast bud, rib, vertebra and limb next door).[1]

Happle has pushed the idea one step further, speculating that some cases may rest on lethal somatic mutations survived only by mosaicism — variants, notably in the beta-actin gene ACTB, that would kill in the germline but are tolerated when marooned in a single skin clone. It is viva gold precisely because it sounds exotic and is still the prevailing speculative framework.[10]

Epidemiology — common, male, and mostly invisible to doctors

Becker's naevus is common; you just rarely see it, because most lesions never reach a doctor. The prevalence you quote — about 0.25% of young men — comes from screening surveys of military recruits and university students, where the trunk is examined as a matter of course. Clinic-based estimates are far lower, because the asymptomatic majority never present.[1]

The lesion is more frequent in males — ratios between 2:1 and 5:1 — for the same androgen reason as everything else in the topic. There is no real link to sun, skin type or ethnicity; the lesion is described worldwide, though dark coarse body hair simply makes the hypertrichosis more conspicuous and more likely to drive the visit. Females are probably under-counted on both counts — less common and more often overlooked.[1][3]

Clinical presentation — tempo, topography, texture

Becker's naevus tells its story through tempo, topography and texture, and a careful look usually closes the diagnosis without a single investigation. The lesion classically appears in peripuberty — 10 to 15 years — as a faint light-brown macule the family first mistakes for a bruise, a "dirty patch" or a birthmark that "suddenly appeared".[1]

After the growth spurt the lesion stabilises in early adulthood and then sits there, unchanged, for life. It does not regress. Some patients notice mild darkening in pregnancy or with exogenous androgens, which is the hormone responsiveness showing itself again.[1]

The morphology to carry into the exam: light- to dark-brown colour, an irregular geographic border that is never the smooth oval of a café-au-lait macule, a flat-to-slightly-thickened surface with a faint rubbery induration from the smooth-muscle hyperplasia, and coarse dark terminal hair confined strictly to the pigmented patch. Intralesional acne may sit on top.[9]

The distribution is unilateral and respects Blaschko's lines. Bilateral or multiple lesions are rare and should make you think paradominant kindred or the syndrome rather than two ordinary naevi.[1]

Although the shoulder girdle owns the teaching image, the lesion can declare anywhere. Alhusayen and colleagues catalogued Becker's naevus on the lower limb — the exam point being that an atypical site does not exclude the diagnosis, but it should lower your threshold for biopsy to rule out the mimics.[8]

Symptomatically the lesion is usually asymptomatic. Mild pruritus turns up occasionally, and intralesional acne may be sore. The dominant complaint is cosmetic — the prominent hair and the large pigmented patch on an exposed shoulder are embarrassing in a self-conscious adolescent, and that psychological burden, not any physical danger, is the real reason patients come in.[1]

The differential — and the one discriminator that ends it

Pubertal onset plus a unilateral geographic patch plus confined hypertrichosis is distinctive; the differentials only bite when the picture is atypical. When the lesion is early (no hair yet), sits on an odd site, or first appears in adulthood, run it against this table:[1]

The two distinctions examiners love are Becker's versus café-au-lait macule and Becker's versus congenital melanocytic naevus. Learn the discriminator line for each and you have answered the stem before they finish asking it.[1]

Hair inside the patch = Becker's; hairless, smooth and oval = CALM. Multiple hairless smooth macules point you to NF1, not to a hamartoma. Born with it, dark, lumpy and full of naevus cells = CMN; arrived at puberty, geographic and naevus-cell-free = Becker's.[1]

Congenital smooth-muscle hamartoma — a sibling, not a stranger

Congenital smooth-muscle hamartoma (CSMH) is the closest relation and the most debated. It presents at or near birth as a firm, skin-coloured to lightly pigmented plaque, often on the trunk, with vellus or terminal hair and prominent, sometimes 'Michelin-tyre' skin folds. Histology shows mature smooth-muscle bundles in the dermis with little epidermal change. Many dermatopathologists read Becker's naevus and CSMH as two ends of one hamartoma spectrum — Becker's when epidermal pigment and hair dominate, CSMH when smooth muscle dominates — distinguished by which element is loudest. A positive pseudo-Darier sign (the plaque indurates or piloerects on rubbing) is the bedside clue that smooth muscle is in the lesion.[1]

At the bedside — pseudo-Darier and the Wood's lamp

The diagnosis of Becker's naevus is clinical, made at the bedside; investigation is the exception. A focused examination does two jobs at once — it confirms the lesion and it screens for the syndrome.[1]

• Inspect for colour, border, size and the coarse terminal hair lying strictly within the patch — the single feature that parts it from a CALM.
• Palpate for the subtle induration of the underlying smooth-muscle hyperplasia; a light rub may induce piloerection confined to the lesion.
• Examine in good light for intralesional acne or comedones.
• Examine the whole integument for extra lesions, which are rare and should make you think paradominant kindred or syndrome.[1]

A Wood's lamp (long-wave UVA) accentuates the pigmentation, confirming its largely epidermal (melanin) origin — dermal pigmentation such as naevus of Ota barely moves under it. A useful bedside discriminator, not a requirement.[1]

Two named manoeuvres earn marks because they sound alike and are mechanistically different:[1]

• Pseudo-Darier sign — firm rubbing induces transient induration, perifollicular papules or piloerection confined to the patch, as the hypertrophied arrector pili smooth muscle contracts. This is the bedside signature of the smooth-muscle component of Becker's naevus.
• Confined piloerection — cold or stroking produces gooseflesh limited to the lesion, again the smooth-muscle hyperplasia. Mechanistically distinct from the true Darier sign of mastocytosis, which is mast-cell degranulation with urtication and erythema — both are 'rub and watch', but the wheal belongs to the mast cell and the goose-bump to the muscle.[1]

Look past the skin — Becker's naevus syndrome

Whenever a Becker's naevus is large, sits on the chest wall, or belongs to a female, the examination is not finished at the skin. Happle, who named and defined the syndrome, framed it as the same mosaic clone spilling into the developmental fields next door — so the cutaneous hamartoma and the ipsilateral defects are one event read across tissues.[2][5]

Screen deliberately for the associated anomalies:[2][5]

• Breasts — inspect and palpate for ipsilateral breast hypoplasia or asymmetry, the commonest and most characteristic associated feature, especially in females.
• Spine — inspect for scoliosis and vertebral anomalies; palpate the spinous processes.
• Chest wall — look for rib or pectoral hypoplasia and asymmetry.
• Limbs — compare length and girth; look for limb hypoplasia or asymmetry.[1]

The syndrome is probably under-recognised, because the breast and skeletal anomalies can be subtle and are not always sought. The classic trap is stopping at the patch. A chest-wall Becker's naevus in a girl may be the surface sign of an underdeveloped breast beneath — and that hypoplasia is usually far more distressing to her than the pigmentation ever was.[5]

Investigations — usually none

Becker's naevus is a clinical diagnosis; investigation is the exception, reserved for atypical presentation or genuine doubt. Biopsy is not routine. Reach for it only when the presentation is atypical — unusual site such as face or lower limb, absent hypertrichosis, onset in adulthood, or bilateral and multiple lesions — when a changing or nodular component within a patch raises melanoma concern (vanishingly rare, but any change in a pigmented lesion earns dermoscopy and, if needed, a biopsy), or when clinical and Wood's-lamp assessment has left you genuinely uncertain.[1]

When you do biopsy, histopathology shows the hamartomatous triad — acanthosis, papillomatosis and elongated rete ridges with increased basal melanin but no extra melanocytes, enlarged mature terminal-hair follicles, and increased mature smooth muscle that stains with SMA — and, crucially, up-regulated androgen receptors in the basal keratinocytes and follicular outer root sheath. The decisive negative is again the absence of naevus cells.[1][3]

Dermoscopy is supportive, not diagnostic: a regular network with thickened lines, prominent widened follicular openings housing the terminal hairs, and perifollicular hypopigmentation — and, importantly, no melanoma-specific features. Imaging is not required for the uncomplicated lesion; for suspected syndrome, request chest/breast imaging (mammography, ultrasound or MRI), spinal imaging (plain films or MRI) and long-film limb radiographs as the clinical findings direct.[1]

Management — reassure first, laser last, never excise the big one

There is no resuscitative component to Becker's naevus — nothing here is an emergency — and the cornerstone of management is a confident diagnosis delivered as reassurance. That reassurance is itself therapeutic for the anxious adolescent who has been told at home that the "mole" might turn nasty.[1]

Explain it in plain language: a common, benign, hormone-responsive birthmark-like patch that "switches on" at puberty; it is not a mole, not cancer, and will not turn into cancer. Tell them the lesion will stabilise after the pubertal growth phase, persist unchanged for life, and carry no malignant potential — and then address the cosmetic concern directly, because for most adolescents the visible hair and the large brown patch are the entire problem.[1]

The cosmetic ladder — pigment laser and hair laser are not the same tool

When cosmetic concern drives the request for treatment, management is stepwise and multimodal, because no single device deals with both the pigment and the hair. You are always running two ladders at once — combination therapy is the rule, not the clever extra.[1][7]

Step 1 — Reassurance and observation. For most patients, explanation alone is enough. The risks and costs of laser — multiple sessions, variable response, recurrence — outweigh the benefit when the lesion is tolerated.[1]

Step 2 — Camouflage. Colour-matched paramedical camouflage make-up is the reversible, non-procedural option for the adolescent who wants to conceal the patch for a social occasion without committing to a laser course.[1]

Step 3 — Laser for pigmentation. Q-switched lasers target the melanin granules in the basal layer.[1]

Everyone forgets: pigment response is variable and frequently incomplete, and the pigmentation often recurs, because the androgen-driven basal keratinocytes keep overproducing melanin underneath the laser. Post-inflammatory hyperpigmentation is a real risk in darker phototypes. Warn the patient before they consent, and counsel realistic outcomes — those who expect a cure are the ones who come back disappointed.[6][7]

Step 4 — Laser for hypertrichosis. The coarse terminal hair responds better than the pigment, because the follicle is a discrete, pigmented target.[1]

Long-pulsed alexandrite, diode and Nd:YAG deliver sustained hair reduction over sessions spaced to the hair-growth cycle. Hair reduction is generally more satisfactory and more durable than pigment reduction, and is often the single intervention that most improves patient satisfaction.[1]

Step 5 — Combination and adjunctive therapy. The current consensus, set out in the 2022 update by Zhou and colleagues, is that combination protocols outperform single-modality treatment: a Q-switched pigment laser plus a long-pulsed hair laser, sometimes with ablative fractional laser resurfacing as an adjunct for texture and pigment-laser penetration. Treatment is individualised, outcomes are partial, and setting expectations is the single biggest determinant of satisfaction.[6][7]

Step 6 — Surgical excision (rare). Reserved for small, discrete lesions in a location where the scar would be acceptable and the patient is deeply troubled. For the typical large shoulder or chest patch, the scar is cosmetically worse than the lesion — so excision is generally inappropriate, and there is no role whatever for wide excision "to prevent" anything, because the lesion is benign.[1]

The pitfalls of treatment are all variations on the same theme — over-promising on a benign lesion: recurrence of pigmentation, post-inflammatory hyperpigmentation after laser (especially in darker phototypes), incomplete hair removal needing maintenance, and unacceptable scarring from excision or overly aggressive laser. None of these is acceptable in a purely cosmetic indication, which is why counselling comes first.[1]

Managing the syndrome and the atypical presentations

The cutaneous component of Becker's naevus syndrome is managed like any Becker's naevus — reassurance plus laser if desired — but the associated anomalies need active, age-appropriate intervention.[1]

The defects are managed in their own lanes: ipsilateral breast hypoplasia — the most psychologically significant defect in females — gets surgical reconstruction (tissue-expander and implant-based, or autologous flap), deferred until breast development is complete, with psychological support through adolescence; scoliosis and vertebral anomalies get orthopaedic monitoring through the growth years, with bracing or surgical correction if the curve progresses; limb asymmetry gets orthopaedic assessment for limb-length discrepancy, with epiphysiodesis or lengthening in selected cases; and chest-wall hypoplasia gets plastic or thoracic input for significant pectus or rib anomalies. A named multidisciplinary pathway — dermatology, plastic surgery, orthopaedics, breast or endocrine medicine, psychology — is the model, otherwise these patients get fragmented skin-only care that misses the developmental defects underneath.[5]

At atypical sites the lesion is histologically identical to the classical one — Alhusayen's lower-limb review confirms it — but an odd site should lower the threshold for biopsy to exclude linear epidermal naevus and dermal melanocytosis. Rare familial kindreds show vertical transmission compatible with paradominant inheritance; a family history should prompt examination of relatives and counselling about the low risk of transmission. And in females, even a cosmetically tolerated chest-wall patch may herald underdevelopment of the ipsilateral breast, which warrants careful evaluation regardless of how the patient feels about the skin.[8][4]

Acne confined to a Becker's naevus is a recognised, occasionally the presenting, phenomenon: the androgen-responsive pilosebaceous units inside the patch throw comedones and inflammatory papules. Juhl and colleagues reported it in a 14-year-old girl, and it doubles as a tidy teaching point — the lesion is, by definition, androgen-responsive, so of course it can develop its own private patch of acne.[9]

Prognosis — benign, stable, lifelong

The prognosis is excellent. The lesion enlarges through the pubertal growth phase, then stabilises in early adulthood and persists, unchanged, for life. It does not regress spontaneously, carries no malignant potential, and has no impact on lifespan or general health. No case of malignant transformation of a Becker's naevus has ever been reported — any nodular change, rapid darkening or ulceration within a patch should still be biopsied, but on the universal principle that any changing pigmented lesion is assessed, not because Becker's naevus carries intrinsic malignant risk.[1]

Disposition is primary care or dermatology outpatient. Refer to dermatology for diagnostic confirmation, for access to the cosmetic laser ladder, or when the syndrome is suspected and a multidisciplinary assessment (breast, orthopaedic, plastic) is needed. Follow-up is not required for an uncomplicated, stable lesion; discharge with advice to return only if the lesion changes or if cosmetic treatment is later desired. Satisfaction after any treatment tracks the pre-treatment counselling far more closely than the objective lightening — those who understand the improvement will be partial and that maintenance is needed are the ones who stay satisfied.[6]

In children the lesion typically declares at 10 to 15 years, though a faint patch may be visible earlier; parents need reassurance about the benign course and realistic counselling that the lesion will darken and grow hair at puberty, and biopsy is avoided unless the diagnosis is genuinely in doubt. Pregnancy may darken a Becker's naevus on its hormonal surge — cosmetic and partial, no intervention required. And a child with the syndrome needs developmental and skeletal surveillance — scoliosis, limb-length discrepancy and breast development monitored through the growth years, with timely orthopaedic and plastic input. That is the one setting in which Becker's naevus is not a "leave it alone" diagnosis.[1]

Evidence, guidelines and regional differences

There are no formal international guidelines for Becker's naevus. Practice rests on case series, narrative reviews and expert consensus, because the condition is benign, uncommon in the clinic, and nobody's research priority. The absence of randomised trials is unsurprising and is not a weakness of practice — recruitment to a sham-controlled laser trial would be near-impossible, and no sponsor has prioritised it.[1]

What the evidence does show converges on the laser question. Q-switched pigment lasers (Nd:YAG 1064 nm, ruby 694 nm, alexandrite 755 nm) give variable, often partial lightening with frequent recurrence — pigment is the harder target. Long-pulsed hair lasers (alexandrite, diode, Nd:YAG) give more reliable hair reduction, usually the more satisfying outcome. Combination protocols outperform single modalities, and post-inflammatory hyperpigmentation is the principal adverse event, particularly in darker phototypes. The two most-cited syntheses — Patel's 2015 overview and Zhou's 2022 update — reach concordant conclusions. The paradominant inheritance model and the speculation on lethal beta-actin variants survived by mosaicism remain the prevailing genetic frameworks, though the precise molecular lesion is uncharacterised in most cases.[6][7][4][10]

The live controversies are three: whether ablative fractional resurfacing as an adjunct is worth its scarring risk on a benign indication; whether to treat during the active pubertal growth phase (when the lesion is still darkening) or wait until stabilisation — most practitioners wait, to avoid treating a moving target; and whether Becker's naevus and congenital smooth-muscle hamartoma are ends of one spectrum or genuinely distinct entities.[1]

Ward-round test

Exam pearls

Red flags

Summary

Becker's naevus is a benign, androgen-dependent cutaneous hamartoma of epidermis, hair follicle and arrector pili smooth muscle that switches on at puberty as a large, unilateral, geographic brown patch with hypertrichosis on the shoulder, chest or back. The diagnosis is clinical; histology shows basal hyperpigmentation, acanthosis and smooth-muscle hyperplasia without naevus cells. The lesion stabilises after puberty, persists for life, and carries no malignant potential. Reassurance is first-line; the cosmetic ladder — camouflage, Q-switched laser for pigment, long-pulsed laser for hair, and only rarely excision of a small lesion — is reserved for those who request it. Becker's naevus syndrome — ipsilateral breast hypoplasia and skeletal anomalies — must be sought in any chest-wall lesion, particularly in females. The molecular basis is a postzygotic somatic (paradominant) mutation producing a localised mosaic clone along the lines of Blaschko. The mantra for the topic: puberty, patch, pili — then reassure; look past the skin for the syndrome.[1]